|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.7900 - 0.8650|
|52 Week Range||0.6550 - 5.3300|
|Beta (3Y Monthly)||2.05|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2019 - Nov 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MariMed Inc. (MRMD) a leading multi-state cannabis operator focused on health and wellness, today announced that Dr. Jokūbas Žiburkus, chief innovation officer and Dr. Eva Selhub, an independent director on MariMed’s board, will participate as industry speakers at the Medical Cannabis Patient Therapies & Wellness Summit in Newton, MA November 14th and 15th.
MariMed Inc. (MRMD:OTCQX) a leading multi-state cannabis and hemp operator focused on health and wellness, today provided financial information for both the three and nine-month periods ended September 30, 2019. For the three months ended September 30, 2019, total revenues increased 231% to $11.22 million compared to the same period of 2018. This revenue was derived from management fees, licensing fees, and real estate income related to MariMed’s owned and/or operated cannabis facilities which grew 24% to $4.21 million in addition to $ 7.01 million from its Hemp business.
MariMed Inc. (MRMD:OTCQX), a premier cannabis and hemp multi-state operator, announced today that on November 7, 2019 the Massachusetts Cannabis Control Commission (CCC) approved ARL Healthcare to commence operations at its Cultivation and Production facility in New Bedford and its Dispensary in Middleborough.
NORWOOD, Mass., Oct. 31, 2019 -- MariMed Inc. (MRMD:OTCQX) today announced its chief innovation officer, Dr. Jokūbas Žiburkus, spoke at the European American Cannabis Business.
Bob Fireman, CEO and president of Marimed Inc (OTC: MRMD), began his presentation by highlighting the industry's responsibility to patients and their medical conditions. Children with epilepsy need precision-dosed products like MariMed's, the CEO said. Medical cannabis licensed producer Indiva Ltd (OTC: NDVAF) has consumer packaged goods executives who hail from major players, including NESTLE S A/S ADR (OTC: NSRGY), General Mills, Inc. (NYSE: GIS) and Clorox Co (NYSE: CLX).
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has signed a definitive agreement to license its market leading brands and products, Betty’s Eddies™ and Kalm Fusion™, to Tropizen of Puerto Rico. Additionally, MariMed will become a licensee to manufacture and distribute Tropizen’s unique tropical products, Pique hot sauce and Real Fruit Gummies in the six states that MariMed serves in the US. Tropizen is a leading cultivator, manufacturer, distributor and retailer of cannabis products in Puerto Rico servicing nearly all of the island’s 100 dispensaries with world-class flower, edibles, topicals and concentrate products. Puerto Rico’s medical market is experiencing dynamic growth.
MariMed Inc. (MRMD) today announced that the Illinois Department of Financial and Professional Regulation has approved the transfer of ownership of its two cannabis-licensed clients, KPG Anna and KPG Harrisburg. The completion of these previously announced transactions will allow MariMed to report the operational results of these businesses in their consolidated financial statements effective October 1, 2019. This acquisition moves MariMed closer to the completion of the consolidation of its cannabis client businesses it developed and manages in multiple states.
Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - MariMed Inc. (OTCQX: MRMD), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound. For more information and/or to register for the conference please visit: https://benzingacannabisconference.com/chicago/?utm_source=newsfile&utm_medium=press_release&utm_campaign=newsfileAbout the ConferenceThe ...
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has appointed Phil Frankenberg as president of its MariMed Hemp subsidiary. MariMed Hemp develops industry-leading CBD brands, and markets them to retailers and direct to consumers worldwide. Frankenberg will focus on raising awareness and driving sales of MariMed Hemp’s top-quality hemp-derived CBD brands, including Florance™ and Healer.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has elected Eva Selhub, MD to its board of directors. Dr. Selhub, also known as Dr. Eva, is an internationally recognized resiliency expert, physician, author, speaker, scientist and consultant. Board certified in internal medicine, she has served as an instructor of medicine at Harvard Medical School.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, announced that the HempEngine™ group of its MariMed Hemp subsidiary has signed an exclusive agreement with one of the largest beverage distributors located in the Northeast U.S., serving more than 8,500 on- and off-premise locations.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, today announced its support of GenCanna Global USA’s engagement of Goldman Sachs & Co. LLC (Goldman Sachs) to serve as its financial advisor to assist in evaluating an initial public offering and other strategic financing alternatives. MariMed became GenCanna’s largest shareholder in February 2019 after making a significant investment to help fund GenCanna’s expansion of its Kentucky operations, and currently owns approximately one-third of the company. GenCanna’s Kentucky farmer’s network is proceeding with the harvest of over 7,000 acres of quality hemp plants which will be processed at GenCanna’s Winchester Kentucky processing center.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, announced today its MariMed Hemp division will exhibit its Florance™ brand of CBD products at Natural Products Expo East being held at the Baltimore Convention Center on September 11-14, 2019. MariMed invites attendees to stop by the company’s booth #4902 where it will exhibit its full line of Florance Hemp CBD products in several categories, including health, beauty, pain and sports. Dr. Jokubas Zirbucus, MariMed’s chief innovation officer and one of the founders of the Florance brand, has organized an experienced medical team to develop new formulations that produce consistent and satisfying results for consumers and patients.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a special permit to allow its Panacea Wellness™ dispensary in Middleborough to merchandise cannabis products under the Massachusetts adult use program. It will now proceed at the Cannabis Control Commission (CCC) for adult use final approval. The dispensary has already received town approval for medical use.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a certificate of occupancy from the city of New Bedford, Massachusetts for its new cannabis cultivation and manufacturing facility. “ARL Healthcare, our Massachusetts cannabis licensed subsidiary, will now schedule its final state inspection to be cleared to commence full operations of its cultivation, production and dispensary,” said Bob Fireman, MariMed’s CEO. The New Bedford manufacturing facility is part of a 137,000 sf building situated on 17 acres providing for future growth and expansion.
The OTCQX® Best Market is top tier of OTC Markets; provides exchange-quality trading experience with superior information availability for investorsMRMD to begin trading on.
NEW YORK , Aug. 15, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced MariMed Inc. (OTCQX: MRMD), a multi-state ...
NORWOOD, Mass., Aug. 12, 2019 -- MariMed Inc. (MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, reported record results for both the.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has engaged CMA, a leading capital markets advisory firm, to lead a new strategic investor relations program. MariMed has rapidly emerged as a premier seed-to-sale cannabis and hemp multi-state operator, providing highest quality products for enhanced customer and patient wellness, state-of-the-art facilities, and recognized brands. The company also owns a significant percentage of GenCanna Global USA, Inc., the Kentucky-based, national leader in cultivation and production of seed-to-sale cGMP quality CBD derived from hemp.
MariMed Hemp, a subsidiary of MariMed, Inc. (MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, has launched the Hemp Engine™, a turnkey retail marketing platform for the fast-growing CBD sector. The platform supports sales and marketing decisions for a wide range of CBD products based on quality, popularity and price point, allowing distributors and retailers to maximize returns and increase sales efficiency. Co-developed with Sprout™, the leading CRM provider to the cannabis industry, the platform is driven by proprietary data and technology.
Under the terms of the agreements, MariMed is licensed to manufacture and distribute the Binske portfolio of products in seven states: Illinois, Ohio, Massachusetts, Rhode Island, Maryland, Delaware, and Maine, adding substantially to the availability of Binske brands, which are currently licensed in Colorado, Nevada, Florida, and California. The Binske brands include a variety of consumer options, including concentrates, edibles, vaporizers, and topicals. Ryan Crandall, MariMed's Chief Product Officer and SVP Sales, stated, "Binske is a popular brand in Colorado and Nevada, and we are enthusiastic about the potential of its products in the markets where we operate. Binske will be an exciting addition to the diverse portfolio of seven brands MariMed currently owns and licenses, such as Betty's Eddies™, Nature’s Heritage™ and Kalm Fusion™, among others.
Cannabis brand Binske announced Monday it has partnered with the multistate operator MariMed Inc (OTC: MRMD) in a licensing deal. Binske products are presently found in Colorado, Nevada, California and Florida. Under the deal, products will become available in Ohio, Maryland, Illinois, Massachusetts, Rhode Island, Delaware and Maine.
MariMed Inc. (MRMD), a leading multi-state cannabis operator focused on health and wellness, announced the appointment of Mr. Jonathan Rider to the newly created position of Chief Information Officer, effective immediately. Mr. Rider brings over 25 years of technology experience to MariMed and has held multiple senior leadership positions across various industries, with a consistent focus on supporting global business operations.